Aurinia Pharmaceuticals Inc (AUPH)

Aurinia Pharmaceuticals Inc (AUPH) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	11.55% 50.30	45.09	54.52	41.49	34.41
Cost Of Revenue	43.69% 7.752	5.395	6.769	1.563	0.421
Gross Profit	7.18% 42.55	39.70	47.75	39.93	33.99
Operating Expenses	25.36% 55.80	74.77	70.78	57.66	63.99
Interest Income/Expense	2.06% 1.283	1.31	1.40	0.065	-
Benefits Costs and Expenses	60.31	-	-	-	-
Costs And Expenses	15.00% 63.56	74.77	70.78	57.66	63.99
Operating Income/Loss	55.34% -13.25	-29.67	-16.26	-16.17	-29.58
Income/Loss From Continuing Operations Before Tax	122.20% -10.01	45.09	-13.15	-12.13	-25.77
Income Tax Expense/Benefit	61.00% 0.739	0.459	0.298	-0.642	0.436
Income/Loss From Continuing Operations After Tax	60.00% -10.75	-26.88	-13.45	-11.49	-26.21
Net Income/Loss	60.00% -10.75	-26.88	-13.45	-11.49	-26.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95,273% 144.01	0.151	142.85	142.78	142.64
Diluted Average Shares	95,273% 144.01	0.151	142.85	142.78	142.64
Basic Earnings Per Share	63.16% -0.07	-0.19	-0.09	-0.08	-0.18
Diluted Earnings Per Share	63.16% -0.07	-0.19	-0.09	-0.08	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-